£1.2M
The funding round was backed by existing investors Mercia Ventures, NorthStar Ventures and North East Finance.
NB
Newcells Biotech
Newcells Biotech develops advanced in vitro cell models to reduce reliance on animal testing.
£8.8MTotal raised
Newcastle-based life sciences company developing laboratory models of human tissues for drug and chemical discovery. It was spun out from the University of Newcastle in 2015.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Newcells Biotech's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
MN
Mike Nicholds
CEO
Mike brings leadership and commercial experience from biotechnology and business services, currently serving as chief executive officer at Newcells Biotech and managing director at Cels Business Services.
LinkedInAH
Andrew Hair
Media contact
LA
Lyle Armstrong
LinkedIn
Mark Carnegie-Brown
Chair
Mark brings governance and leadership experience from roles including chair of Newcells Biotech and trustee of the South East Rivers Trust. His background also includes executive positions at Concept Life Sciences and Malvern Panalytical.
LinkedInInvestors
- £1.2M
- £2.4M
- £5.3M
Funding history
£2.4M
The funding round was backed by Mercia Ventures, Northstar Ventures, and the North East Venture Fund.
£5.3M
Newcells Biotech secures £5.3m from Mercia and NorthStar Ventures to expand international operations
The seed follow-on round from existing backers Mercia and NorthStar Ventures will fund international expansion in the US and accelerate product launches.